GlassScriptPhysician profile
Jennifer E Wilson
NPI 1932464500
$1,343.17
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $164 · 2021: $276 · 2024: $21.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $269.74 | 2019-2021 | |
| Novo Nordisk INC | $179.36 | 2019-2020 | |
| Pfizer INC. | $131.37 | 2019 | |
| Smith+Nephew, INC. | $108.14 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.01 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.65 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $72.72 | 2019-2020 | |
| Amgen INC. | $70.22 | 2019-2021 | |
| Lilly USA, LLC | $67.85 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $49.06 | 2021 | |
| Hologic Sales and Service, LLC | $41.29 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Glaxosmithkline, LLC. | $36.54 | 2021 | |
| Horizon Therapeutics Plc | $30.82 | 2020-2021 | |
| Allergan, INC. | $29.98 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $29.44 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $18.69 | 2019 | |
| Insulet Corporation | $15.00 | 2020 | |
| Abbvie INC. | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.